Cargando…
An Inflammatory Response-Related Gene Signature Can Predict the Prognosis and Impact the Immune Status of Lung Adenocarcinoma
SIMPLE SUMMARY: Lung adenocarcinoma (LUAD) is a highly prevalent and deadly global malignancy with an annual increase in its incidence. The association of inflammation with tumor genesis and development has been of interest in recent years. However, the association of inflammatory response-related g...
Autores principales: | Shi, Yubo, Zhao, Yingchun, Wang, Yuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736863/ https://www.ncbi.nlm.nih.gov/pubmed/36497225 http://dx.doi.org/10.3390/cancers14235744 |
Ejemplares similares
-
An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2021) -
A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Li, et al.
Publicado: (2022) -
Identification of Inflammatory Response-Related Gene Signature Associated With Immune Status and Prognosis of Lung Adenocarcinoma
por: Zou, Weijie, et al.
Publicado: (2021) -
A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Xuewen, et al.
Publicado: (2022) -
A novel tetraspanin-related gene signature for predicting prognosis and immune invasion status of lung adenocarcinoma
por: Zhu, Yindong, et al.
Publicado: (2023)